{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:09:56Z","timestamp":1778713796132,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060459"],"award-info":[{"award-number":["82060459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcp.2026.117905","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:17:00Z","timestamp":1773728220000},"page":"117905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer therapy"],"prefix":"10.1016","volume":"249","author":[{"given":"Hui","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanpeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7485-2017","authenticated-orcid":false,"given":"Lanlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-591X","authenticated-orcid":false,"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10061","key":"10.1016\/j.bcp.2026.117905_b0010","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer[J]","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0015","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41598-020-80853-6","article-title":"Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity[J]","volume":"11","author":"Arita","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2026.117905_b0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1535-7163.MCT-23-0121","article-title":"Correction: pharmacologic activation of STING in the bladder induces potent antitumor immunity in non\u2013muscle invasive murine bladder cancer[J]","volume":"22","author":"Huang","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bcp.2026.117905_b0025","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1158\/1535-7163.MCT-16-0924","article-title":"Epidermal growth factor receptor (EGFR)-targeted photoimmunotherapy (PIT) for the treatment of EGFR-expressing bladder cancer[J]","volume":"16","author":"Railkar","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways[J]","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.bcp.2026.117905_b0035","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.3390\/cancers14246203","article-title":"Natural products\/bioactive compounds as a source of anticancer drugs[J]","volume":"14","author":"Asma","year":"2022","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.bcp.2026.117905_b0040","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/1871520621666210126091512","article-title":"Sanguinarine: a double-edged sword of anticancer and carcinogenesis and its future application prospect[J]","volume":"21","author":"Lou","year":"2021","journal-title":"Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents."},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0045","article-title":"Sanguinarine attenuates lung cancer progression via oxidative stress-induced cell apoptosis[J]","volume":"17","author":"Ullah","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063425","article-title":"Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1[J]","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer[J]","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5644\/ama2006-124.332","article-title":"New insights into the diagnosis, molecular taxonomy and treatment of bladder cancer[J]","volume":"50","author":"Ulamec","year":"2021","journal-title":"Acta Medica Academica."},{"issue":"6","key":"10.1016\/j.bcp.2026.117905_b0065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.euo.2024.01.014","article-title":"Benefit of neoadjuvant cisplatin-based chemotherapy for invasive bladder cancer patients treated with radiation-based therapy in a real-world setting: an inverse probability treatment weighted analysis[J]","volume":"7","author":"Kool","year":"2024","journal-title":"European Urology Oncology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer[J]","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer drug discovery based on natural products: from computational approaches to clinical studies[J]","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines."},{"issue":"4","key":"10.1016\/j.bcp.2026.117905_b0080","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/molecules27041378","article-title":"An update of the sanguinarine and benzophenanthridine alkaloids' biosynthesis and their applications[J]","volume":"27","author":"Laines-Hidalgo","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41420-023-01376-3","article-title":"Targeting oxeiptosis-mediated tumor suppression: a novel approach to treat colorectal cancers by sanguinarine[J]","volume":"9","author":"Pallichankandy","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2026.117905_b0090","doi-asserted-by":"crossref","unstructured":"Cui, Y., Luo, Y., Qian, Q., et al. Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT\/\u03b2-Catenin Pathway[J].Front Oncol. 2022,12 732860.","DOI":"10.3389\/fonc.2022.732860"},{"issue":"12","key":"10.1016\/j.bcp.2026.117905_b0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41419-019-2173-1","article-title":"Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1\u03b1\/TGF-\u03b2 feed-forward loop in hepatocellular carcinoma[J]","volume":"10","author":"Su","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117905_b0100","doi-asserted-by":"crossref","unstructured":"Cui, Y., Luo, Y., Qian, Q., et al. Sanguinarine regulates tumor-associated macrophages to prevent lung cancer angiogenesis through the WNT\/\u03b2-catenin pathway[J].Frontiers in Oncology. 2022,12 732860.","DOI":"10.3389\/fonc.2022.732860"},{"issue":"11","key":"10.1016\/j.bcp.2026.117905_b0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery[J]","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.1016\/j.bcp.2026.117905_b0110","article-title":"The value of epidermal growth factor receptor expression in predicting aggressive behaviors of bladder neoplasms[J]","volume":"15","author":"Yazdi","year":"2023","journal-title":"Nephro-Urology Monthly."},{"key":"10.1016\/j.bcp.2026.117905_b0115","doi-asserted-by":"crossref","unstructured":"Li, W., Wang, Y., Tan, S., et al. Overexpression of epidermal growth factor receptor (EGFR) and HER-2 in bladder carcinoma and its association with patients\u2019 clinical features[J].Medical science monitor: international medical journal of experimental and clinical research. 2018,24 7178.","DOI":"10.12659\/MSM.911640"},{"key":"10.1016\/j.bcp.2026.117905_b0120","doi-asserted-by":"crossref","unstructured":"Scholtes, M., Akbarzadeh, M., Zwarthoff, E., et al. Targeted therapy in metastatic bladder cancer: Present status and future directions[J].Applied Sciences. 2020,10 (20): 7102.","DOI":"10.3390\/app10207102"},{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/molecules27030819","article-title":"Structural insight and development of EGFR tyrosine kinase inhibitors[J]","volume":"27","author":"Amelia","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0130","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.apsb.2015.07.001","article-title":"Mechanisms of resistance to EGFR tyrosine kinase inhibitors[J]","volume":"5","author":"Huang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2026.117905_b0135","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.21037\/tlcr.2019.04.20","article-title":"Epidermal growth factor receptor first generation tyrosine-kinase inhibitors[J]","volume":"8","author":"Martinez-Marti","year":"2019","journal-title":"Transl Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-022-01375-4","article-title":"Drugging KRAS: current perspectives and state-of-art review[J]","volume":"15","author":"Parikh","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0145","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.3892\/ijo.2021.5270","article-title":"Mechanisms and management of 3rd\u2011generation EGFR\u2011TKI resistance in advanced non\u2011small cell lung cancer (Review)[J]","volume":"59","author":"He","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2026.117905_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109726","article-title":"Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K\/Akt\/mTOR pathway[J]","volume":"122","author":"Rong","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.bcp.2026.117905_b0155","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/ijms20092188","article-title":"PI3K\/AKT\/mTOR signaling regulates the virus\/host cell crosstalk in HPV-positive cervical cancer cells[J]","volume":"20","author":"Bossler","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0160","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ijms23031353","article-title":"Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma[J]","volume":"23","author":"Barzegar Behrooz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117905_b0165","doi-asserted-by":"crossref","unstructured":"Yu, L., Wei, J., Liu, P., in: Seminars in cancer biology, Elsevier, 2022, pp. 69-94.","DOI":"10.1016\/j.semcancer.2021.06.019"},{"key":"10.1016\/j.bcp.2026.117905_b0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process[J]","volume":"165","author":"Roshan","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2026.117905_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.06.004","article-title":"Targeting the genetic alterations of the PI3K\u2013AKT\u2013mTOR pathway: Its potential use in the treatment of bladder cancers[J]","volume":"145","author":"Hou\u00e9d\u00e9","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117905_b0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4939-7234-0_23","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in bladder cancer[J]","author":"Sathe","year":"2018","journal-title":"Urothelial Carcinoma Methods and Protocols."},{"key":"10.1016\/j.bcp.2026.117905_b0185","doi-asserted-by":"crossref","unstructured":"Jain, R., Watson, U., Vasudevan, L., et al. ERK activation pathways downstream of GPCRs[J].International review of cell and molecular biology. 2018,338 79-109.","DOI":"10.1016\/bs.ircmb.2018.02.003"},{"issue":"22","key":"10.1016\/j.bcp.2026.117905_b0190","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.3390\/ijms222212530","article-title":"FOXO3a and its regulators in prostate cancer[J]","volume":"22","author":"Habrowska-G\u00f3rczy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117905_b0195","doi-asserted-by":"crossref","unstructured":"Monte, A., Bezerra, M., Menezes, V., et al. Involvement of phosphorylated Akt and FOXO3a in the effects of growth and differentiation Factor-9 (GDF-9) on inhibition of follicular apoptosis and induction of granulosa cell proliferation after in vitro culture of sheep ovarian tissue[J].Reproductive Sciences. 2021,28 2174-2185.","DOI":"10.1007\/s43032-020-00409-x"},{"key":"10.1016\/j.bcp.2026.117905_b0200","doi-asserted-by":"crossref","unstructured":"Shanshan, W., Hongying, M., Jingjing, F., et al. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt\/FoxO3a\/Puma axis[J].Toxicology in Vitro. 2024,97 105801.","DOI":"10.1016\/j.tiv.2024.105801"},{"issue":"12","key":"10.1016\/j.bcp.2026.117905_b0205","first-page":"8539","article-title":"Sanguinarine promotes apoptosis of hepatocellular carcinoma cells via regulating the miR-497-5p\/CDK4 axis[J]","volume":"14","author":"Ding","year":"2022","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.117905_b0210","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/biomedicines10081795","article-title":"Sanguinarine induces H(2)O(2)-dependent apoptosis and ferroptosis in human cervical cancer[J]","volume":"10","author":"Alakkal","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ddr.21315","article-title":"Sanguinarine induces apoptosis of human oral squamous cell carcinoma KB cells via inactivation of the PI3K\/Akt signaling pathway[J]","volume":"77","author":"Lee","year":"2016","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bcp.2026.117905_b0220","doi-asserted-by":"crossref","unstructured":"Akhtar, S., Achkar, I.W., Siveen, K.S., et al. Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2\/STAT3 Signaling[J].Front Oncol. 2019,9 285.","DOI":"10.3389\/fonc.2019.00285"},{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41422-021-00597-4","article-title":"Pre-ribosomal RNA reorganizes DNA damage repair factors in nucleus during meiotic prophase and DNA damage response[J]","volume":"32","author":"Gai","year":"2022","journal-title":"Cell Res."},{"issue":"18","key":"10.1016\/j.bcp.2026.117905_b0230","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4161\/cc.7.18.6679","article-title":"DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells[J]","volume":"7","author":"Mao","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2026.117905_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \u201cundruggable\u201d MYC[J]","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment[J]","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.117905_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0728-0","article-title":"The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance[J]","volume":"37","author":"Weng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117905_b0250","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/antiox10050642","article-title":"Oxidative stress in cancer cell metabolism[J]","volume":"10","author":"Arfin","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00109-022-02281-5","article-title":"FoxO3 and oxidative stress: a multifaceted role in cellular adaptation[J]","volume":"101","author":"Bernardo","year":"2023","journal-title":"J. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.117905_b0260","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy[J]","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.actatropica.2010.08.003","article-title":"Antioxidant, larvicidal and antiacetylcholinesterase activities of cashew nut shell liquid constituents[J]","volume":"117","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/j.bcp.2026.117905_b0270","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2012.931","article-title":"Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients[J]","volume":"4","author":"Zitka","year":"2012","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2026.117905_b0275","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/molecules28031447","article-title":"Glutathione-related enzymes and proteins: a review[J]","volume":"28","author":"Va\u0161kov\u00e1","year":"2023","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bcp.2026.117905_b0280","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom10101429","article-title":"Role of glutathione in cancer: from mechanisms to therapies[J]","volume":"10","author":"Kennedy","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.bcp.2026.117905_b0285","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1039\/D0CS00718H","article-title":"Engineering nanomedicine for glutathione depletion-augmented cancer therapy[J]","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"13","key":"10.1016\/j.bcp.2026.117905_b0290","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond[J]","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.117905_b0295","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements[J]","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.117905_b0300","article-title":"Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1\u03b1 pathways in breast cancer[J]","volume":"153503","author":"Su","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.117905_b0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13020-024-00881-6","article-title":"Sanguinarine chloride induces ferroptosis by regulating ROS\/BACH1\/HMOX1 signaling pathway in prostate cancer[J]","volume":"19","author":"Liu","year":"2024","journal-title":"Chin. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:19:41Z","timestamp":1778710781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226002388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"alternative-id":["S0006295226002388"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117905","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting EGFR with sanguinarine chloride: a novel approach to bladder cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117905"}}